Once-daily oral paltusotine in the treatment of patients with carcinoid syndrome: Biomarker analysis results from a phase 2, randomized, parallel-group study.
Document Type
Conference Proceeding
Publication Date
1-11-2026
Publication Title
Journal of Clinical Oncology
First Page
632
Last Page
632
Volume
44
Publisher
American Society of Clinical Oncology
Rights
Copyright © 2026 by the American Society of Clinical Oncology
Recommended Citation
Oviedo Albor, Ana Isabel; Mohamed, Amr; Riechelmann, Rachel; O'Connor, Juan Manuel; Maluccio, Mary Alice; Singh, Simron; Hajac, Lukasz; Demeure, Michael J.; Dillon, Joseph S.; Shaheen, Shagufta; Althoff, Juliana Lorenzoni; Dioca, Mariano Dioca; Halfdanarson, Thorvardur Ragnar; Hendifar, Andrew; Quidute, Ana Rosa Pinto; Scandizzo, Mariana; Markova, Denka; Xiao, Zhimin; Chauhan, Aman; and Anthony, Lowell Brian, "Once-daily oral paltusotine in the treatment of patients with carcinoid syndrome: Biomarker analysis results from a phase 2, randomized, parallel-group study." (2026). School of Medicine Faculty Publications. 4829.
https://digitalscholar.lsuhsc.edu/som_facpubs/4829
10.1200/JCO.2026.44.2_suppl.632